Nhà máy Stada
Analgesics & Antipyretics



Pack size:

Box of 20 sachets x 1 g


Each sachet of oral effervescent powder contains paracetamol 250 mg.


24 months from the date of manufacturing.

Store in a well-closed container, in a dry place. Protect from moisture.

Do not store above 30oC.

  • Indications and Dosage & Administration
  • Contraindications
  • Adverse reactions
  • Precautions

  • For treatment of mild to moderate pain and fever, especially in patients in whom salicylates are contraindicated or not tolerated.
    The drug is most effective in relieving low intensity pain of non-visceral origin.
  • Administered orally. The effervescent powder must be dissolved in water and the solution should then be drunk after the powder dissolved completely.

  • Paracetamol should not be used for self-medication of pain for longer than 5 days in children.
  • Paracetamol should not be used for self-medication of marked fever (greater than 39.5oC), fever persisting longer than 3 days, or recurrent fever.
  • Adults: 0.5 - 1 g (2 - 4 sachets) every 4 - 6 hours to a maximum of 4 g daily.

  • Children: Children may be received the following doses every 4 - 6 hours as necessary:
    Under 12 months old: should be dosed using other preparation.
    1- 6 years: 120 - 250 mg (½ - 1 sachet) to maximum 4 doses in 24 hours.
    6-12 years: 250 - 500 mg (1-2 sachets) to maximum 4 doses in 24 hours.
    12-18 years: 500 mg (2 sachets) every 4-6 hours.

Or as advised by physicians.


  • Patients with anemia or cardiae, pulmonary, renal, or hepatic disease.
  • Patients with known hypersensitivity to paracetamol.
  • Patients with known glucose-6- phosphate dehydrogenase deficiency.


  • Adverse effects of paracetamol are rare and usually mild.
  • Haematological: Thrombocytopenia, leucopenia, pancytopenia, neutropenia and agranulocytosis.
  • Kidneys: Nephropathy when abuse or prolonged excessive use of paracetamol.
  • Respiratory: Asthma.
  • Hypersensitivity: Angioedema, eruptions.


  • Paracetamol is relatively nontoxic in therapeutic doses. Dermatologic have sometimes reactions including pruritic maculopapular rash and urticaria; other sensitivity reactions including laryngeal edema, angioedema, and anaphylactoid reactions may occur rarely.
  • Thrombocytopenia, leukopenia,and pancytopenia have been associated with the use of p-aminophenol derivatives, especially with prolonged administration of large doses.
  • Neutropenia and thrombocytopenic purpura have been reported with paracetamol use.
  • Rarely, agranulocytosis has been reported in patients receivingparacetamol.
  • Individuals with phenylketonuria (i.e., homozygous deficiency of phenylalanine hydroxylase) who must restrict their intake of phenylalanine should be warned that PARTAMOL 250 contain aspartame, which is metabolized in the gastrointestinal tract to phenylalanine following oral administration.
  • Paracetamol should be used with caution in patients with preexisting anemia, since cyanosis may not be apparent despite dangerously high blood concentrations of methemoglobin.
  • Excessive intake of alcohol may increase the risk of paracetamol induced hepatotoxicity; avoid or limit alcohol intake.
  • Caution is recommended when giving to patients with hepatic or renal impairment.
  • The physicians need to warn the patients of the signs of serious skin reactions known as Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) or Lyell's syndrome, acute generalized exanthematous pustulosis (AGEP).
  • Pregnancy: Paracetamol is generally considered to be the analgesic of choice in pregnant patients. However, the frequent use of paracetamol in late pregnancy may be associated with an increased risk of persistent wheezing in the infant. Paracetamol infrequent should remain the analgesic of choice in pregnancy.
  • Lactation: No adverse effects have been observed in breast-fed infants whose mothers were receiving paracetamol, the amount of paracetamol distributed into breast milk is too small to be harmful to a breast-fed infant.
  • Effects on ability to drive and use machines: None known.


Contact us

FACTORY 1: K63/1 Nguyen Thi Soc St., Xuan Thoi Dong, Hoc Mon, HCMC
Tel: +84 28 3718 2141 - Fax: +84 28 3718 2140

FACTORY 2: 40 Tu Do Avenue, VietNam-Singapore Industrial Park, Binh Duong
Tel: +84 274 376 7470 - Fax: +84 274 376 7469
Email : stada@stada.com.vn
Website: www.stada.com.vn

Visitors Counter